Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

210 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic.
Walsh SL, Eissenberg T. Walsh SL, et al. Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S13-27. doi: 10.1016/s0376-8716(03)00056-5. Drug Alcohol Depend. 2003. PMID: 12738347 Review.
Acute administration of buprenorphine in humans: partial agonist and blockade effects.
Walsh SL, Preston KL, Bigelow GE, Stitzer ML. Walsh SL, et al. J Pharmacol Exp Ther. 1995 Jul;274(1):361-72. J Pharmacol Exp Ther. 1995. PMID: 7542336 Clinical Trial.
Absence of acute cocaine interactions with the MAO-B inhibitor selegiline.
Haberny KA, Walsh SL, Ginn DH, Wilkins JN, Garner JE, Setoda D, Bigelow GE. Haberny KA, et al. Among authors: walsh sl. Drug Alcohol Depend. 1995 Jul;39(1):55-62. doi: 10.1016/0376-8716(95)01137-n. Drug Alcohol Depend. 1995. PMID: 7587975 Clinical Trial.
Effects of buprenorphine and methadone in methadone-maintained subjects.
Walsh SL, June HL, Schuh KJ, Preston KL, Bigelow GE, Stitzer ML. Walsh SL, et al. Psychopharmacology (Berl). 1995 Jun;119(3):268-76. doi: 10.1007/BF02246290. Psychopharmacology (Berl). 1995. PMID: 7675960 Clinical Trial.
Fluoxetine alters the effects of intravenous cocaine in humans.
Walsh SL, Preston KL, Sullivan JT, Fromme R, Bigelow GE. Walsh SL, et al. J Clin Psychopharmacol. 1994 Dec;14(6):396-407. J Clin Psychopharmacol. 1994. PMID: 7884020 Clinical Trial.
Buprenorphine reduces cerebral glucose metabolism in polydrug abusers.
Walsh SL, Gilson SF, Jasinski DR, Stapleton JM, Phillips RL, Dannals RF, Schmidt J, Preston KL, Grayson R, Bigelow GE, et al. Walsh SL, et al. Neuropsychopharmacology. 1994 May;10(3):157-70. doi: 10.1038/npp.1994.18. Neuropsychopharmacology. 1994. PMID: 7916913 Clinical Trial.
Clinical pharmacology of buprenorphine: ceiling effects at high doses.
Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Walsh SL, et al. Clin Pharmacol Ther. 1994 May;55(5):569-80. doi: 10.1038/clpt.1994.71. Clin Pharmacol Ther. 1994. PMID: 8181201
Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
Schuh KJ, Walsh SL, Bigelow GE, Preston KL, Stitzer ML. Schuh KJ, et al. Among authors: walsh sl. J Pharmacol Exp Ther. 1996 Aug;278(2):836-46. J Pharmacol Exp Ther. 1996. PMID: 8768738
Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.
Walsh SL, Sullivan JT, Preston KL, Garner JE, Bigelow GE. Walsh SL, et al. J Pharmacol Exp Ther. 1996 Nov;279(2):524-38. J Pharmacol Exp Ther. 1996. PMID: 8930154 Clinical Trial.
The effects of buprenorphine in buprenorphine-maintained volunteers.
Strain EC, Walsh SL, Preston KL, Liebson IA, Bigelow GE. Strain EC, et al. Among authors: walsh sl. Psychopharmacology (Berl). 1997 Feb;129(4):329-38. doi: 10.1007/s002130050199. Psychopharmacology (Berl). 1997. PMID: 9085402 Clinical Trial.
210 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback